Cancer cells
A team of researchers at the University of Bonn has made a groundbreaking discovery in the field of ovarian cancer treatment. In a study published in Cell Death Discovery, the researchers investigated the efficacy of PARP inhibitors in treating ovarian cancer cells that are resistant to cisplatin, a commonly used
Cancer research
A major international trial, led by researchers from the University of College London (UCL), has found that a new combination of drugs significantly delays the progression of a life-threatening form of prostate cancer in men with specific genetic mutations. The Phase III AMPLITUDE trial tested the addition of niraparib, a
Cancer research
Researchers at IMVARIA Inc. have achieved a major technological advancement in the development of a fully-automated Bronchosolve solution, designed to diagnose lung cancer non-invasively through the assessment of suspicious pulmonary nodules. The platform, which has been tested in the pivotal VIRTUAL-BRONCH Study, has demonstrated improved accuracy relative to standard clinical
Cancer research
A recent study published in the Journal of Experimental & Clinical Cancer Research has shed light on the mechanisms of immunosuppression in ovarian cancer, a type of cancer that affects women's reproductive organs. Researchers from Shanghai First Maternity and Infant Hospital in China have discovered a novel feedback
Cancer research
Researchers at the University of Genoa in Italy have made significant contributions to the understanding of PD-L1 expression in gastric cancer. A new report presents findings from a multicentric, real-world retrospective study that analyzed data from 28 Italian pathology centers, covering 1936 cases of esophageal, esophagogastric junction, and gastric carcinoma
Cancer research
Clinical trial findings suggest that patients with limited metastases from recurrent prostate cancer can experience a significantly longer interval before disease progression when treated with a radiopharmaceutical drug before targeted radiation therapy, compared to radiation alone. The phase II LUNAR trial, presented at the American Society for Radiation Oncology (ASTRO)
Cancer research
A study published in the Kosin Medical Journal revealed that there were significant changes in surgical treatment for colorectal cancer during the COVID-19 pandemic. Researchers from Kosin University Gospel Hospital analyzed the medical records of 757 patients who underwent colorectal cancer surgery between January 2019 and December 2021. The study
Cancer research
Data from a prospective observational study conducted at the Arnau de Vilanova Hospital in Valencia, Spain, has revealed significant insights into the immune response of breast cancer patients undergoing active treatment. The research, focusing on the immunogenicity of SARS-CoV-2 mRNA vaccine in this population, demonstrated a strong humoral response with
Cancer research
Contrast-enhanced mammography (CEM) has emerged as a valuable tool in breast cancer screening, offering enhanced diagnostic accuracy compared to standard mammography. Researchers from Ohio State University Wexner Medical Center have published a study in RadioGraphics, highlighting the benefits and limitations of CEM in clinical practice. The study emphasizes the importance
Cancer research
Men with genes that increase their risk of prostate cancer should have annual checks from the age of 40, research has shown. The Institute of Cancer Research study found that men carrying particular BRCA gene mutations are at an even higher risk of developing aggressive prostate disease. The UK National
Cancer research
Men carrying the BRCA1 or BRCA2 gene mutations, like Angelina Jolie, should undergo routine prostate screening from the age of 40, according to the Institute for Cancer Research. This, in turn, could detect prostate cancer earlier, when treatment is more effective. The institute recommends annual NHS checks for this high-risk
Cancer research
Experts at The Institute of Cancer Research, London, are urging men with BRCA1 and BRCA2 gene mutations to undergo annual prostate cancer screening, citing evidence that targeted PSA testing can pick up more aggressive cancers at a younger age. The recommendation comes after five years of data from the international
